(RHHBY) The Agreement Closes the Litigation Between the Parties BOULDER, Colo., Aug. 29, 2025 /PRNewswire/ -- Foresight Diagnostics ("Foresight") today announced that it has entered into a limited licensing agreement with Roche Molecular Systems and Roche Sequencing Systems (together, "Roche")...
Related Questions
How will the licensing agreement with Roche affect Foresight Diagnostics' revenue and profitability in the next 12 months?
What are the specific terms and duration of the limited licensing deal, and how might they influence the valuation of both companies?
How does this partnership position Foresight and Roche relative to competitors in the Non‑Hodgkin's Lymphoma diagnostic market?